Getting CRISPR to market: solve delivery, manufacturing issues - STAT

Getting CRISPR to market: solve delivery, manufacturing issues - STAT

CRISPR-Cas9 commercialization may be slowed by delivery and manufacturing challenges

By JIM BURNS

MARK SCHIEFELBEIN/AP

There's great promise in CRISPR-Cas9 gene-editing "drugs" if companies can solve two challenges: how to deliver them to cells and how to make enough.

READ MORE